139 related articles for article (PubMed ID: 25444901)
1. A small peptide derived from p53 linker region can resume the apoptotic activity of p53 by sequestering iASPP with p53.
Qiu S; Cai Y; Gao X; Gu SZ; Liu ZJ
Cancer Lett; 2015 Jan; 356(2 Pt B):910-7. PubMed ID: 25444901
[TBL] [Abstract][Full Text] [Related]
2. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.
Bergamaschi D; Samuels Y; O'Neil NJ; Trigiante G; Crook T; Hsieh JK; O'Connor DJ; Zhong S; Campargue I; Tomlinson ML; Kuwabara PE; Lu X
Nat Genet; 2003 Feb; 33(2):162-7. PubMed ID: 12524540
[TBL] [Abstract][Full Text] [Related]
3. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel isoform of iASPP and its interaction with p53.
Zhang X; Diao S; Rao Q; Xing H; Liu H; Liao X; Wang M; Wang J
J Mol Biol; 2007 May; 368(4):1162-71. PubMed ID: 17391696
[TBL] [Abstract][Full Text] [Related]
5. Oncogene iASPP enhances self-renewal of hematopoietic stem cells and facilitates their resistance to chemotherapy and irradiation.
Jia Y; Peng L; Rao Q; Xing H; Huai L; Yu P; Chen Y; Wang C; Wang M; Mi Y; Wang J
FASEB J; 2014 Jul; 28(7):2816-27. PubMed ID: 24668753
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cells.
Zhang B; Xiao HJ; Chen J; Tao X; Cai LH
Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):219-24. PubMed ID: 21625267
[TBL] [Abstract][Full Text] [Related]
7. miR-129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63-dependent manner.
Zou H; Zou R; Chen K; Zhu C; Tian X; You Y; He X
J Cell Biochem; 2018 Nov; 119(11):9217-9228. PubMed ID: 30105797
[TBL] [Abstract][Full Text] [Related]
8. Effect of RNA interference of iASPP on the apoptosis in MCF-7 breast cancer cells.
Liu ZJ; Cai Y; Hou L; Gao X; Xin HM; Lu X; Zhong S; Gu SZ; Chen J
Cancer Invest; 2008 Nov; 26(9):878-82. PubMed ID: 18798069
[TBL] [Abstract][Full Text] [Related]
9. Abnormal expression pattern of the ASPP family of proteins in human non-small cell lung cancer and regulatory functions on apoptosis through p53 by iASPP.
Li S; Shi G; Yuan H; Zhou T; Zhang Q; Zhu H; Wang X
Oncol Rep; 2012 Jul; 28(1):133-40. PubMed ID: 22552744
[TBL] [Abstract][Full Text] [Related]
10. siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53.
Liu H; Wang M; Diao S; Rao Q; Zhang X; Xing H; Wang J
Leuk Res; 2009 Sep; 33(9):1243-8. PubMed ID: 19299014
[TBL] [Abstract][Full Text] [Related]
11. A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP.
Woodard C; Liao G; Goodwin CR; Hu J; Xie Z; Dos Reis TF; Newman R; Rho H; Qian J; Zhu H; Hayward SD
J Virol; 2015 Sep; 89(18):9232-41. PubMed ID: 26109723
[TBL] [Abstract][Full Text] [Related]
12. Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells.
Qiu S; Liu S; Yu T; Yu J; Wang M; Rao Q; Xing H; Tang K; Mi Y; Wang J
BMC Cancer; 2017 Nov; 17(1):795. PubMed ID: 29179704
[TBL] [Abstract][Full Text] [Related]
13. A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells.
Li H; Zhang W; Zhao K; Zhao D; Zheng S; Hu Y
J Biol Chem; 2020 Mar; 295(12):4049-4063. PubMed ID: 32005663
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection and expressions of apoptosis-related proteins p53, ASPP2 and iASPP in gastric cancer and precancerous lesions.
Meng WD; Chu RX; Wang BZ; Wang LP; Ma LL; Wang LX
Pathol Biol (Paris); 2013 Oct; 61(5):199-202. PubMed ID: 23528480
[TBL] [Abstract][Full Text] [Related]
15. iASPP protects the heart from ischemia injury by inhibiting p53 expression and cardiomyocyte apoptosis.
Yagudin T; Zhao Y; Gao H; Zhang Y; Yang Y; Zhang X; Ma W; Daba TM; Ishmetov V; Kang K; Yang B; Pan Z
Acta Biochim Biophys Sin (Shanghai); 2021 Jan; 53(1):102-111. PubMed ID: 33128543
[TBL] [Abstract][Full Text] [Related]
16. 2-anilino-4-amino-5-aroylthiazole-type compound AS7128 inhibits lung cancer growth through decreased iASPP and p53 interaction.
Cheng HW; Chein RJ; Cheng TJ; Wu PS; Wu HY; Hung PF; Wang CJ; Hsu YL; Wong JM; Yuan A; Wong CH; Yang PC; Pan SH
Cancer Sci; 2018 Mar; 109(3):832-842. PubMed ID: 29285847
[TBL] [Abstract][Full Text] [Related]
17. iASPPsv antagonizes apoptosis induced by chemotherapeutic agents in MCF-7 cells and mouse thymocytes.
Wang L; Xing H; Tian Z; Peng L; Li Y; Tang K; Rao Q; Wang M; Wang J
Biochem Biophys Res Commun; 2012 Aug; 424(3):414-20. PubMed ID: 22766503
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory member of the apoptosis-stimulating proteins of the p53 family (iASPP) interacts with protein phosphatase 1 via a noncanonical binding motif.
Llanos S; Royer C; Lu M; Bergamaschi D; Lee WH; Lu X
J Biol Chem; 2011 Dec; 286(50):43039-44. PubMed ID: 21998301
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of ASPP2, iASPP and p53 in cervical cancinoma and the significance].
Ouyang M; Hu Y; Zeng F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 40(3):256-60. PubMed ID: 25832528
[TBL] [Abstract][Full Text] [Related]
20. [Expression of ASPP gene family and its relationship with survival of patients with non-small cell lung cancer].
Su M; Gu Y; Su S; Lu B
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):268-72. PubMed ID: 24989912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
